Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-01 01:51:17 - browse：7

Lung cancer under microscope — coverage from STAT — Lung cancer Adobe

CHICAGO — Delfi Diagnostics, a company seeking to develop liquid biopsy tests to help screen for lung cancer, published a scientific paper on Monday describing key aspects of the test and unveiled the design of a key clinical trial.

Delfi also announced that the Merck Global Health Innovation Fund, the VC arm of the drug giant, has made an investment of an undisclosed amount in the company.

Unlike Grail, a unit of Illumina, or Exact Sciences, which seeks to develop a blood test that can be used to screen for multiple types of cancer, Delfi is focusing on a single disease — lung cancer — in which the utility of screening with existing technology is not in dispute. Using low-dose CT scans to detect lung cancer is considered an established technology for people at higher risk of lung cancer. However, far too few people get screened.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Biotech lab space demand falls sharply

WSS

NYC plans to house migrants on an island in the East River

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

The UK government moves asylum

Intarcia’s device

FDA panel to weigh approval of NurOwn, controversial ALS drug

focus

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medical student insurance fails on mental health care coverage

Malaria cases in Florida and Texas: Here’s what you need to know

Democratic lawmaker calls for 'well

Jerome Adams on the need for new antivirals for Covid

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

In Memoriam: Notable people who died in 2023

Senators: Long

Sports medicine is finally prioritizing gender equality

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

focus

'The Exorcist' director William Friedkin dead at 87

Moderna hits safety problems in bold bid to reinvent medicine

Why are Kaiser Permanente staff considering a strike?

'The Exorcist' director William Friedkin dead at 87

FDA panel to weigh approval of NurOwn, controversial ALS drug

In medicine, common shorthands can shortchange care

focus

focus

knowledge

Wikipedia